论文信息 - P-565 A Phase II study of KOS-862 (Epothilone D) as second-linetherapy in non-small cell lung cancer - 字舞流文

P-565 A Phase II study of KOS-862 (Epothilone D) as second-linetherapy in non-small cell lung cancer

T. Lynch | N. Rizvi | M. Villalona-Calero | G. Palmer | N. Gabrail | A. Sandler | L. Yee | G. Cropp | M. Graham